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Introduction
An increasing trend in emotional and behav-
ioral disorders in early childhood has been 
observed in the last 10 years (Boyle et al. 
2011). Attention deficit/hyperactivity disorder 
(ADHD) is a psychiatric disorder that is 
characterized by attention deficits, hyperac-
tivity, and impulsivity and is one of the most 
common emotional and behavioral disorders 
among children, with a worldwide prevalence 
estimated at about 5% (Polanczyk et al. 2007). 
Genetic inheritance is believed to play a major 
role in the etiology of ADHD. Twin studies 
have shown a high concordance of inattentive-
ness, with heritability estimated to range from 
70% to 95% (Greven et al. 2011; Willcutt 
et al. 2000b); however, twin studies have not 
shown a high concordance for hyperactive 
or impulsive behaviors (Greven et al. 2011; 
Paloyelis et al. 2010; Willcutt et al. 2000a).
Recent studies suggest that environmental 
toxicants contribute to the risk of ADHD 
(Polanska et al. 2012; Tarver et al. 2014). 
Several case–control studies (Braun et al. 2006; 
Kim et al. 2013; Sánchez-Villegas Mdel et al. 
2014; Wang et al. 2008) and cross-sectional 
studies (Froehlich et al. 2009; Ha et al. 2009; 
Nicolescu et al. 2010; Roy et al. 2009) have 
demonstrated associations between elevated 
blood lead levels and general ADHD behavior. 
However, only a few studies had examined 
lead exposure with regards to subtypes of 
ADHD. Some have shown that lead exposure 
is associated with hyperactive-impulsive behav-
iors, but not with attention problems (Boucher 
et al. 2012a; Nigg et al. 2008, 2010b). The 
mechanism of lead contributing to the risk of 
ADHD, especially with regard to the different 
behavior subtypes, remains unclear.
The objective of this study was to explore 
the association between concurrent lead 
exposure and the prevalence of ADHD behav-
iors in environmental lead–exposed Mexican 
children 6–13 years of age, with regard to three 
subtypes: hyperactivity, inattention, and the 
combination of hyperactivity and inattention.
Materials and Methods
Study Population
The study population was part of two birth 
cohorts of mother–infant pairs enrolled in 
Mexico City, Mexico, starting in 1997 and 
2001, as part of the parent project known 
as the Early Life Exposure in Mexico to 
ENvironmental Toxicants (ELEMENT) 
study (Téllez-Rojo et al. 2006). Pregnant 
women were initially recruited from prenatal 
clinics of the Mexican Social Security Institute 
in Mexico City, which serves a low- to 
middle-income population formally employed 
in the private sector. Potential participants 
were excluded if they exhibited any factor 
that could interfere with maternal calcium 
metabolism or a family or personal history of 
a calcium-related disorder, had intention not 
to breastfeed, serious pregnancy-related condi-
tions, taking corticosteroid medications, or 
were a single parent. They were later excluded 
if their child had any of the following at 
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Background: Previous studies suggest that blood lead levels are positively associated with 
attention deficit/hyperactivity disorder (ADHD) and ADHD-symptoms in children. However, the 
associations between lead exposure and ADHD subtypes are inconsistent and understudied.
oBjective: The objective of this study was to explore the association of low-level concurrent lead 
exposure with subtypes of ADHD symptoms in 578 Mexican children 6–13 years of age.
Methods: We measured concurrent blood lead levels using inductively coupled plasma mass spec-
trometry (ICPMS). We administered the Conners’ Rating Scales-Revised (CRS-R) to mothers to 
evaluate their children’s ADHD symptoms. We used imputation to fill missing values in blood lead 
levels and used segmented regression models adjusted for relevant covariates to model the nonlinear 
relationship between blood lead and ADHD symptoms.
results: Mean ± SD blood lead levels were 3.4 ± 2.9 μg/dL. In adjusted models, a 1-μg/dL 
increase in blood lead was positively associated with Hyperactivity and Restless-Impulsivity scores 
on the CRS-R scale and Hyperactivity-Impulsivity scores on the CRS-R scale of the Diagnostic 
and Statistical Manual of Mental Disorders, 4th Edition, but only in children with blood lead level 
≤ 5 μg/dL. Blood lead was not associated with Inattentive symptoms or overall ADHD behavior.
conclusions: In this population of Mexican children, current blood lead level among children 
with low exposure (≤ 5 μg/dL) was positively associated with hyperactive/impulsive behaviors, but 
not with inattentiveness. These results add to the existing evidence of lead-associated neurodevelop-
mental deficits at low levels of exposure.
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birth: gestational age < 37 weeks, birth weight 
< 2,000 g, Apgar score at 5 min of ≤ 6, admit-
tance to the NICU (neonatal intensive-care 
unit), or a serious birth defect. Initial follow-
up of the 1,079 children born to these two 
cohorts assessed growth and neurodevelop-
ment at 6-month intervals until 5 years of age. 
Children were invited to the Department of 
Developmental Neurobiology at the Instituto 
Nacional de Perinatología for an additional 
follow-up visit between 2008 and 2011; 622 
(58%) participated in the follow-up study 
when they were 6–13 years of age. Of those, 
39 subjects were newly enrolled younger 
siblings of the study subjects from the original 
cohorts and were therefore excluded because 
they were missing baseline information. The 
remaining 583 (93.7%) mother–child pairs 
participated in the behavioral assessment visit 
as part of the follow-up study. An additional 
5 subjects with birth weight < 2,000 g were 
excluded, leaving a total of 578 subjects in 
this analysis. The research was approved by 
the institutional review boards of the National 
Institute of Public Health of Mexico and all 
of the participating hospitals and institutions. 
Written informed consent and/or assent were 
obtained from all participants.
Lead Exposure Measurements
A total of 166 of 578 children who partici-
pated in the study declined phlebotomy, 
leaving 412 children in the study with 
blood samples. Whole blood was collected 
from peripheral veins into trace metal–free 
tubes after sanitation at the lancet site. Blood 
samples were shipped to the University of 
Michigan and maintained at –80°C until 
analysis. A total of 342 samples were analyzed 
in the ISO (International Organization for 
Standardization)–designated clean room to 
minimize the contamination possibilities 
in University of Michigan Department of 
Environmental Health Sciences Metals 
Laboratory using inductively coupled 
plasma mass  spectrometry  ( ICPMS) 
(Agilent 7500c; Agilent Technologies, 
Palo Alto, CA). Accuracy and precision 
were estimated by use of certified refer-
ence materials (Institut National de Santé 
du Québec; INSPQ, QMEQAS09) as well 
as replicated samples. The average detection 
limit was 0.03 μg/dL. The overall accuracy 
was 88.2% ± 9.5%. As part of the quality 
control step, 70 blood samples including 64 
duplicates were analyzed at the Michigan 
Department of Community Health using 
a similar ICPMS approach with a detec-
tion limit of 1.3 μg/dL and all values above 
the limit of detection (LOD). The overall 
accuracy was 102.4% ± 2%. We performed 
cross- validation between the two laboratories 
in 64 samples and reached a consistency of 
96.2% after removing two outliers.
Behavioral Assessment
At the clinic visit, Conners’ Rating Scale–
Revised (CRS-R) (Conners 2000) was admin-
istered to mothers to assess their children’s 
behavior. CRS-R examines seven types of 
behavior problems in children including: 
Oppositional, Anxious-Shy, Cognitive 
Problem/Inattent ion,  Hyperact iv i ty , 
Perfectionism, Psychosomatic, and Social 
Problems. It also contains four index scores: 
Conners’ ADHD Index; Conners’ Global 
Index (CGI): Restless-Impulsive; CGI: 
Emotional Lability; and CGI: Total. CRS-R 
also includes scales for the Diagnostic and 
Statistical Manual of Mental Disorders, 4th 
Edition (DSM-IV) diagnosis of ADHD: 
a) DSM-IV: Inattentive, b) DSM-IV: 
Hyperactive-Impulsive, and c) DSM IV: 
Total. The Spanish version of this scale has 
been validated in 139 Mexican first-grade 
children (internal reliability = 0.894) for 
the evaluation of ADHD (Ortiz-Luna and 
Acle-Tomasini 2006). We selected scales and 
index scores from CRS-R related to ADHD 
symptoms assessment: Cognitive Problem/
Inattention, Hyperactivity, ADHD Index, 
Conners’ Global Index: Restless-Impulsive, 
and three subscales from DSM-IV symptoms 
subscales (Inattentive, Hyperactive-Impulsive, 
and Total). These scores reflect mainly hyper-
activity, inattentiveness, or overall ADHD 
symptoms. All scales were standardized into 
T-scores. Higher scores indicate an increased 
likelihood that a child would meet diag-
nostic criteria for ADHD. A T-score of 65 
indicates a “clinically significant problem” 
(Conners 2000).
Other Information
ELEMENT has detailed information on 
maternal, child, and familial characteristics 
dating back to pregnancy. In addition, we 
collected updated questionnaire-based infor-
mation on maternal marital status, parental 
education levels, and family socioeconomic 
status (SES) at recruitment for this child 
follow-up study. The socioeconomic question-
naire asked about the availability of certain 
items and assets in the home [number of light 
bulbs in the home, rooms in the house, bath-
rooms, cars, personal computer, water heater, 
electrical appliances (video/DVD player, 
washing machine, vacuum cleaner, toaster, 
microwave), and the type of house floor]. 
Point values were assigned to each item, and 
the SES level was calculated based on the sum 
of the points across all items.
Statistical Analyses
Children’s blood lead levels were missing in 
29% of study subjects because the test subjects 
or their parents declined phlebotomy. In 
addition, a few subjects (< 8%) had missing 
information on behavior tests and covariates 
of interests. We performed single imputation 
to replace all missing values. The imputation 
model assumed that the missing mechanism is 
missing at random (MAR) because declining 
phlebotomy, for example, is unlikely to depend 
on the children’s blood lead levels. The MAR 
assumption is more robust than the missing 
completely at random (MCAR) assumption 
because MCAR assumes that the probability 
of missing does not depend on any observed 
values (Little and Rubin 2002); however, 
in our data, declining phlebotomy occurred 
slightly more often among younger children 
(mean ± SD age for children who declined and 
consented: 8.7 ± 1.3 years vs. 9.2 ± 1.3 years). 
We used chained equations methods in R 
mice package (van Buuren and Groothuis-
Oudshoorn 2011) to impute the missing 
values and used covariates and outcomes in 
the imputation models as recommended by 
Moons et al. (2006). Specifically, we used 
historical children’s blood lead levels at 12, 
18, 24, 36, and 48 months and child’s sex, 
age, birth weight, and neurobehavior outcomes 
from the CRS-R scales, as well as parental 
information such as maternal age, educational 
level, marital status, SES level, smoking status 
during pregnancy, and paternal educational 
level to impute current children’s blood lead 
levels and other missing values. Children’s sex, 
maternal marital status, and smoking status 
during pregnancy were treated as binary vari-
ables, and the rest were treated as continuous 
variables. Briefly, the chained equations proce-
dure first fills out the missing values with the 
variable mean and uses multivariate regres-
sion predictions to update imputed values 
until convergence. We used a predicted mean 
matching approach to select imputed values. 
That is, instead of using the predicted values 
from the regression, this method finds a value 
from the observed data that is close to the 
predicted value for replacement. This method 
has advantages of fast convergence, avoiding 
impossible values, and preserves the nonlinear 
relationship when model is mis- specified. 
We allowed 20 iterations in one imputa-
tion because the authors (Azur et al. 2011; 
van Buuren and Groothuis-Oudshoorn 2011) 
suggested that the convergence can be reached 
between 5 to 10 iterations. We examined the 
imputation convergence by plotting the means 
and standard deviations at each iteration over 
the number of iterations, as recommended 
(van Buuren and Groothuis-Oudshoorn 
2011). We observed that the means and 
standard deviations were randomly distributed 
over iterations without any apparent increasing 
or decreasing trend. This demonstrates that the 
imputations took on plausible values.
We treated blood lead and behavioral 
assessment scores as continuous variables. We 
performed crude bivariate analyses between 
blood lead and CRS-R scales with locally 
Huang et al.
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weighted scatter plot smoothing (LOWESS) 
to examine potential nonlinear dose–response 
relationships. Blood lead did not show a linear 
relationship with behavior tests either before 
or after natural log–transformation. For a 
subset of the outcomes, LOWESS suggested 
that the relationship between blood lead and 
behavioral outcomes was increasing at first, 
followed by a plateau. Therefore, we used 
a segmented regression approach (Muggeo 
2003) to a) identify breakpoints in the associa-
tion (i.e., blood lead level at which tapering off 
of the association occurred), and b) assess the 
linear association between lead and behavioral 
outcomes between breakpoints.
Briefly, the segmented regression method 
assumes linear relationships between predictors 
and outcome within intervals, or segments, of 
the exposure distribution. The method esti-
mates end points for said intervals, or “break-
points,” from the data by iteratively updating 
the breakpoints and the exposure–outcome 
associations (i.e., slopes within the intervals) 
until the difference between the updated values 
and the last estimated values become close 
to 0 (convergence). The model itself cannot 
define the number of the breakpoints or initial 
values to begin the estimation procedure, and 
relies on the user for these specifications. We 
followed recommendations to use several initial 
values to assess sensitivity of the results to user 
input. We first used LOWESS methods to 
visualize nonlinear associations between chil-
dren’s blood lead levels and CRS-R scales (see 
Figure S1). We observed apparent increasing 
trends from 0 to around 5–10 μg/dL on 
CRS-R scales of Hyperactivity, Restless-
Impulsive, and CRS-R and DSM-IV scales of 
Hyperactive-Impulsive and Total and chose 
initial breakpoint values at 1, 8, and 15 μg/dL 
because these values were near the exposure 
levels where the relationships changed as 
observed in the LOWESS plots. For each of 
these initial values, we repeated the models 
at least 10 times and derived breakpoint and 
slope estimates from repeated models. We 
compared the breakpoint and slope estimates 
from repeated models within and across all 
the proposed initial values. For illustration, we 
present the results derived from these initial 
values, with each initial value run twice, in 
Table S1. When a true breakpoint exists in the 
data, the estimation of the breakpoint would 
be stable regardless of the initial values, and 
the confidence intervals (CIs) for the break-
point would be relatively narrow. Otherwise, 
if the breakpoint does not exist, the model 
will fail to converge; yield different estimated 
breakpoints when different initial values are 
used; or give wide confidence intervals for the 
breakpoint. In these cases, the results rendered 
from segmented regressions do not have mean-
ingful biological interpretations. As shown in 
Table S1, the breakpoint estimates stabilized 
between 5.0 and 5.4 on the CRS-R scales 
of Hyperactivity, CGI Restless-Impulsive, 
DSM-IV Hyperactive-Impulsive,  and 
DSM-IV Total. The breakpoint estimates on 
the rest of scales either fell into extreme values 
(< 1 or > 20 μg/dL); the values of breakpoints 
were not consistent when using different initial 
values for iterations (i.e., on ADHD Index, 
the breakpoint switches between around 5 
and 20 μg/dL); or the confidence intervals 
of breakpoints were relatively large (i.e., on 
DSM IV Total, the confidence interval ranges 
from 0.6 to 10.6 μg/dL, covering 29.1% of 
the lead exposure range), indicating the models 
could not find the apparent transitioning 
point for the relationship. Additionally, in 
the scales with low breakpoint values, the 
slope estimates for lower levels of blood lead 
tended to have large negative values, indi-
cating steep decreasing slopes in the range 
of exposure where only a few observations 
were made. Given these criteria, we did not 
consider estimates from the segmented regres-
sion models to be biologically meaningful for 
the CRS-R Cognitive Problem/Inattention 
scale or ADHD Index, or the CRS-R DSM-IV 
Inattentive scale or Total score, and therefore 
used ordinary least square regression instead of 
segmented regression to estimate associations 
for these outcomes. Additionally, from residual 
diagnostic plots, we observed that outcomes 
had larger variance at the higher end of blood 
lead levels (data not shown); to correct this 
violation of the constant variance assump-
tion in the model, we used robust standard 
errors derived using the “sandwich” formula, 
which are also implemented in the R segmented 
package (Muggeo 2008) by using the robust 
standard error option.
Based on previous work (Afeiche et al. 
2011; Zhang et al. 2012), we selected maternal 
marital status, age, educational years, and SES, 
ever smoked during pregnancy, and the child’s 
age at behavioral testing, sex, and birth weight 
as a priori covariates. We also included paternal 
educational years because it was significantly 
correlated with child behavioral outcomes and 
blood lead.
As applicable (i.e., on scales CRS-R 
Hyperactivity, CGI Restless-Impulsive, and 
DSM-IV Hyperactivity), we conducted sensi-
tivity analyses for segmented regressions using: 
a) fixed breakpoints of 5 μg/dL since this is 
the CDC level of concern for lead exposure; 
b) the segmented regression models with 
complete cases only (i.e., excluding observa-
tions with missing values), with breakpoints 
estimated, or fixed at 5 μg/dL or at the esti-
mates obtained with the imputed data; c) a 
subset of data where the blood lead levels were 
measured in the department of Environmental 
Health Sciences laboratory at University of 
Michigan (EHS lab); and d) the imputed data 
set after including five subjects with birth 
weight < 2,000 g. The segmented models 
with fixed breakpoints were estimated using a 
piece-wise linear regression with a single knot 
at the fixed breakpoint.
All statistical analyses were performed 
in R software (R Core Team 2012). All 
significance testing was two-sided and statis-
tical significance was determined at alpha 
level of 0.05.
Results
A total of 578 subjects with various propor-
tions of missing information (29% for blood 
lead levels) on major variables of interest 
were included in this analysis. Table 1 shows 
the characteristics of the study population 
in both incomplete and imputed data. We 
did not observe meaningful differences in the 
distributions of characteristics between the 
imputed and incomplete data. We report the 
statistics from imputed data here. Mean ± SD 
maternal age was 26 ± 5.4 years. Mean 
maternal education was 10.9 ± 2.8 years, 
which was similar to the mean paternal 
education of 10.6 ± 3.5 years. Most (73%) 
mothers were married, and only 18 (3%) 
reported having smoked during pregnancy. 
Average infant birth weight was 3,100 g 
(range, 2,000–4,400 g). Females accounted 
for 50% of children who ranged in age from 
6.2 to 12.5 years at the follow-up visit for 
this study. The means of T-scores on the 
CRS-R subscales were slightly higher than 
the expected T-score means [50 (Conners 
2000)]. About 12% to 20% of subjects on all 
selected scales exceeded the scores of 65, indi-
cating possible clinically significant behavior 
problems (Conners 2000). Consistent with 
expectations, CRS-R scores were lower (indi-
cating fewer symptoms) in children with 
higher maternal and paternal education and in 
children whose mothers were married, whereas 
average scores were higher (indicating more 
symptoms) among children whose mothers 
smoked during pregnancy and in five children 
with low birth weight (data not shown).
Concurrent blood lead at the time of 
neurobehavioral testing had mean ± SD 
values of 3.4 ± 3.1 μg/dL. About 15% 
of subjects had blood lead levels exceeding 
5 μg/dL. Blood lead showed a nonlinear rela-
tionship with a subset of CRS-R responses 
from the LOWESS plot (see Figure S1). 
After adjusting for covariates, the asso-
ciation between blood lead and CRS-R 
Hyperactivity, CRS-R CGI Hyperactive-
Impulsive, and CRS-R DSM-IV Restless-
Impulsive showed breakpoints near 5 μg/dL 
(Figure 1A, Table 2). Below the breakpoint, 
a 1-μg/dL increase in blood lead was associ-
ated with significantly higher scores for each 
of these outcomes, indicating an increase in 
symptoms with higher exposure (Table 2). 
However, the association reached a plateau 
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after the breakpoint, such that a 1-μg/dL 
higher blood lead was not associated with 
higher scores for these outcomes (Table 2). 
The segmented regression approach did not 
find biologically meaningful breakpoints in 
the relationship of blood lead to CRS-R scales 
of Cognitive Problems/Inattention, ADHD 
Index, and CRS-R and DSM IV scales of 
Inattentive and Total. The associations 
between blood lead level and these responses, 
estimated with linear regression, were not 
significant after adjusting for covariates 
(Table 2, rows without breakpoints shown).
The results of the sensitivity analyses 
showed relatively few, and expected, differ-
ences from our primary results shown in 
Table 2 that used imputed data. Upon inclu-
sion of five low birth weight subjects, the 
effect estimates did not change. The models 
using the CDC level of concern for blood 
lead exposure (5 μg/dL) as the breakpoint for 
segmented regression of CRS-R Hyperactivity 
and CRS-R CGI Restless-Impulsive, CRS-R 
DSM IV Hyperactive-Impulsive (see 
Table S2) were similar to estimates using the 
breakpoints identified by the analysis (5.0, 
5.1, 5.2 μg/dL, respectively). Associations 
between low blood lead levels and these 
outcomes also were similar when models 
were limited to children with known values 
of all model variables (n = 362), including 
models that used the same breakpoints as 
in the primary model, and when all break-
points were set to 5.0 μg/dL (see Tables S3 
and S5, respectively). The association was 
similar when applying breakpoints estimated 
in the complete-case data only for blood lead 
levels ≤ 5.0 μg/dL; however, for blood lead 
levels > 5 μg/dL, the estimates were more 
negative but nonsignificant (see Table S4). 
Additionally, estimates were consistent with 
those shown in Table 2 for blood lead levels 
≤ 5.0 μg/dL when based only on 342 samples 
measured at the University of Michigan. 
Sensitivity analyses of outcomes evaluated 
using linear regression (CRS-R Cognitive 
scale and ADHD Index, CRS-R DSM-IV 
Inattentive and Total scales) were consistent 
with those shown in Table 2 when based on 
complete-case data (see Table S3) and samples 
measured at the University of Michigan (see 
Table S6). Finally, estimates were similar for 
all outcomes when five children with low birth 
weight (< 2,000 g) were included in analyses 
using imputed data and model-derived 
breakpoints for segmented regressions (data 
not shown).
Discussion
We found that concurrent blood lead was 
associated with hyperactive and impulsive 
behaviors in 6- to 13-year-old Mexican 
children. However, the association did not 
exhibit a linear relationship. We observed a 
trend of worsening responses associated with 
increasing blood lead levels below approxi-
mately 5 μg/dL, followed by a plateau or 
slightly decreasing trend when blood lead level 
was > 5 μg/dL. We did not observe any asso-
ciation between concurrent blood lead and 
inattentiveness or overall ADHD symptoms in 
these children.
ADHD is a psychiatric disorder with 
prevalence rising from 2.8% to 4.4% 
between 1998 and 2009 in 5- to 17-year-old 
Mexican-American children in the United 
States (Akinbami et al. 2011). Children with 
ADHD are primarily found to have impair-
ments in attention, executive function, 
state regulation, motivation, and processing 
of temporal information (Nigg 2005). 
However, ADHD is highly heterogeneous 
and further classified into three subtypes 
that exhibit distinct behavior patterns: inat-
tentive subtype (ADHD-I), hyperactive 
subtype (ADHD-H), and combined subtype 
(ADHD-C). For example, ADHD-C children 
typically demonstrate sluggish and hypoactive 
behavior, whereas ADHD-I children tend to 
be shy yet active (Carlson and Mann 2002; 
McBurnett et al. 2001). These distinct char-
acteristics suggest that the underlying brain 
function alterations and associated etiologies 
of these ADHD subtypes may be different. 
Twin studies also support this idea, indicating 
high heritability of inattention, but not of 
hyperactivity or impulsivity (Greven et al. 
2011; Willcutt et al. 2000a). However, the 
studies conducted in young twins could lead 
to overestimation of genetic influence due to 
shared living environments. Recent studies 
have shown mixed findings in the associa-
tions between lead exposure and the subtypes 
of ADHD (Goodlad et al. 2013). There is 
increasing evidence of a link between lead 
exposure and hyperactive behavior (Boucher 
et al. 2012b; Hong et al. 2015; Nigg 2008; 
Nigg et al. 2010a; Sioen et al. 2013). Our 
finding that, among children with blood lead 
levels ≤ 5.0 μg/dL, concurrent blood lead is 
associated with hyperactive and impulsive 
behavior, but not inattention or combined 
subtypes of behavior suggests a potential 
environmental etiology of ADHD-H, which 
genetics alone cannot fully explain.
The dopamine pathway is one of the 
major neurotransmitter pathways involved 
in ADHD (Bellgrove et al. 2005; Carrasco 
et al. 2004; Hamarman et al. 2004; Henríquez 
et al. 2008; Swanson et al. 2000). The asso-
ciation between lead and ADHD symptoms 
in our study population, specifically with 
hyperactivity-impulsivity, may reflect effects 
of lead on the dopamine system (Cory-Slechta 
1995, 1997; Luo et al. 2014). Dopaminergic 
neurons are especially susceptible to oxida-
tive stress due to the reactive oxygen species 
generated during dopamine degradation 
process (Meiser et al. 2013; Miyazaki and 
Asanuma 2008; Sulzer and Zecca 2000). Lead 
may accelerate dopaminergic neuron loss by 
imposing oxidative stress (Chetty et al. 2005; 
Hsu 1981; Lawton and Donaldson 1991; 
Sulzer 2007). Lead also disrupts homeostasis 
of calcium-dependent neurotransmitters, such 
as dopamine (Simons 1993), by competing 
Table 1. Characteristics of parents and children participating in Mexican birth cohort study of lead 
exposure and behavior.
Characteristicsa
Original data Imputed data n = 578
n Percent missing Mean ± SD or n (%) Mean ± SD or n (%)
Behavior assessment 
CRS-R
Cognitive Problem/Inattention 561 2.9 54.0 ± 10.6 54.1 ± 10.5
Hyperactivity 561 2.9 55.5 ± 10.8 55.6 ± 10.7
ADHD Index 560 3.1 54.1 ± 10.5 54.1 ± 10.4
CGI Restless-Impulsive 561 2.9 54.5 ± 10.3 54.6 ± 10.3
CRS-R DSM-IV
CRS: DSM IV Inattentive 561 2.9 53.3 ± 10.2 53.4 ± 10.2
CRS: DSM IV Hyperactive-Impulsive 561 2.9 57.1 ± 10.7 57.1 ± 10.6
CRS: DSM IV Total 561 2.9 55.4 ± 10.4 55.5 ± 10.3
Child characteristics 
Blood lead level (μg/dL) 412 28.7 3.4 ± 2.9 3.4 ± 3.1
Children’s age (years) 578 0 9.1 ± 1.3 9.1 ± 1.3
Children’s sex, female 578 0 289 (50.0) 289 (50.0)
Birth weight (kg) 577 0.2 3.1 ± 0.4 3.1 ± 0.4
Parental characteristics
Maternal age (years) 578 0 26.0 ± 5.4 26.0 ± 5.4
Maternal education (years) 578 0 10.9 ± 2.8 10.9 ± 2.8
Mothers’ marital status, married 578 0 421 (72.8) 421 (72.8)
Smoking during pregnancy, smoked 577 0.2  18 (3)  18 (3)
Paternal education (years) 534 7.6 10.7 ± 3.5 10.6 ± 3.5
SES level index 553 4.3 8.7 ± 3.2 8.8 ± 3.3
SES, socioeconomic status.
aBehavior assessments were conducted at the follow-up visit when children were 6 to 13 years old. Children’s blood 
lead levels, parental information, and SES level index were assessed at the behavior assessment. SES level index was 
calculated by summarization of household assets at follow-up visit. 
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with calcium at its binding sites (Goering 
1993) and inhibits dopamine transporter 
activity (Luo et al. 2014).
Lead exposure has previously been reported 
to be associated with ADHD or ADHD 
symptoms. Higher blood lead levels have been 
observed in children with ADHD (Froehlich 
et al. 2009; Kim et al. 2013; Sánchez-Villegas 
et al. 2014; Wang et al. 2008), and positive 
associations between blood lead and increased 
likelihood of ADHD symptoms or ADHD 
diagnosis have been observed in studies using 
various behavioral scales in cross-sectional 
studies (Froehlich et al. 2009; Ha et al. 2009; 
Nicolescu et al. 2010). The few studies that 
have explored ADHD subtypes suggest that 
lead exposure is likely to result in hyperac-
tivity, impulsivity (Boucher et al. 2012a; 
Cho et al. 2010; Nigg et al. 2008, 2010b) 
and impaired executive functions (Canfield 
et al. 2003b; Roy et al. 2009). Most published 
studies with low lead exposure levels (mean 
blood lead levels ≤ 5 μg/dL) in the past 
decade have shown that lead is associated 
with ADHD at levels between 2 to 4 μg/dL 
measured in whole blood in children between 
3 and 17 years (Braun et al. 2006; Cho et al. 
2010; Froehlich et al. 2009; Ha et al. 2009; 
Kim et al. 2010; Nigg et al. 2008, 2010b). A 
few studies with higher lead exposure levels 
(mean blood lead levels ≥ 10 μg/dL) in the 
study population showed the association when 
blood lead levels are > 10 μg/dL (Roy et al. 
2009; Sánchez-Villegas et al. 2014; Wang 
et al. 2008).
Our study is consistent with most of the 
existing literature suggesting that the asso-
ciation between lead and ADHD-symptoms 
occurs at levels ≤ 5 μg/dL (Braun et al. 2006; 
Cho et al. 2010; Froehlich et al. 2009; Ha 
et al. 2009; Kim et al. 2010; Nigg et al. 2008, 
2010b). Our data showed a clear pattern 
of higher (worse) scores on hyperactivity 
and restless-impulsive behaviors associ-
ated with increasing blood lead ≤ 5 μg/dL. 
As blood lead rose > 5 μg/dL, the data did 
not exhibit continuing increasing trend on 
these scales, perhaps because 85% of subjects 
in our data had blood lead levels ≤ 5 μg/dL 
and only 2.7% of subjects had blood lead 
levels > 10 μg/dL. This exposure distribu-
tion underpowered our ability to interpret 
the dose–response relationship at the higher 
exposure range.
Our study has several limitations. First, 
ADHD behavior is a complex phenotype. The 
mechanism of ADHD inattentive subtypes 
is still not comprehensively understood. For 
instance, deficits in executive function and 
motivation processes that are observed in 
ADHD are not specific to ADHD (Kuntsi 
et al. 2004; Nigg 2005). Additionally, atten-
tion processes are mediated by cognitive 
function. Therefore, the null findings in the 
association of lead with inattentive symptoms 
in our study may not directly reflect on inat-
tentive behavior problem per se. It is worth 
noting that most of the association studies 
of lead and cognition have shown a link 
Table 2. Adjusteda associations between a 1-μg/dL increase in blood lead and CRS-R outcomes in 
children 6–13 years from segmented regressions or least-square regressions using the imputed data set 
(n = 578).
Outcome
Breakpointb  
(95% CI) (μg/dL)
Slope1  
(95% CI)c p
Slope2  
(95% CI) p
CRS-R
Cognitive Problem/Inattention NA –0.03 (–0.3, 0.2) 0.85 NA NA
Hyperactivity 5.0 (2.4, 7.6) 1.2 (0.3, 2.0) 0.01 –0.3 (–0.8, 0.2) 0.26
ADHD Index NA 0.02 (–0.2, 0.3) 0.86 NA NA
CGI Restless-Impulsive 5.1 (2.7, 7.5) 1.2 (0.3, 2.0) 0.007 –0.3 (–0.7, 0.1) 0.15
CRS-R DSM-IV
Inattentive NA 0 (–0.3, 0.3) 0.98 NA NA
Hyperactive-Impulsive 5.2 (2.5, 7.8) 1.1 (0.2, 2.0) 0.02 –0.3 (–0.8, 0.1) 0.15
Total NA 0.03 (–0.2, 0.3) 0.73 NA NA
aAll models were adjusted for maternal marital status, age, educational years, SES, and ever smoked during pregnancy, 
and the child’s age at behavioral testing, sex, and birth weight. bBreakpoints were optimized from iterations in piecewise 
regressions using the imputed dataset. cBiological meaningful breakpoints were not found in the models marked “NA”; 
the estimate shown reflects single slope for the entire range of the exposure distribution estimated using ordinary least-
square regressions.
Figure 1. Adjusted associations (95% CIs; dashed lines) between a 1-μg/dL increase in blood lead and CRS-R outcomes in children 6–13 years of age using the 
imputed data set (n = 578). In each plot, the x-axis represents children’s blood lead levels (μg/dL) on a logarithmic scale; the y-axis represents the Conners Rating 
Scales-Revised (CRS-R) scores. The tick marks on the x-axis indicate the distribution of the observations. (A) Adjusted associations between blood lead and 
CRS-R hyperactive type outcomes from segmented regressions, with each estimated breakpoint and its 95% CI indicated as gray points and line above the x-axis. 
(B) Adjusted associations between blood lead and CRS-R inattentive and overall types outcomes from linear regressions. 
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between declined cognitive functions and lead 
exposure at low (≤ 5 μg/dL) and higher levels 
(i.e., Canfield et al. 2003a; Chandramouli 
et al. 2009; Lanphear et al. 2005). However, 
our inference on the lead exposure–ADHD 
symptoms dose–response relationship is 
limited due to lack of observation at higher 
exposure range. Further analyses are required 
to disentangle the intermediate effects of 
higher brain functioning involved in cogni-
tive processes from those involved in atten-
tion processes. Also, as previously mentioned, 
genetics likely plays a major role in ADHD. 
In this analysis, we examined only the main 
effect of lead exposure without available infor-
mation on family history or genetic markers 
linked to ADHD. Additionally, even though 
we used the CRS-R Spanish version in our 
study, this questionnaire may not be entirely 
culturally appropriate. This may be reflected 
by our data demonstrating higher means than 
expected in the CRS-R scales (Conners 2000). 
We also encountered difficulties in obtaining 
CRS-R evaluations from teachers, which 
could be less subjective than parental ratings. 
However, mothers were blinded to their chil-
dren’s blood lead test results while evaluating 
the children’s ADHD symptoms. It is unlikely 
that their ratings were informatively biased 
according to the children’s concurrent blood 
lead levels. Nevertheless, the information bias 
that may occur in mothers’ response cannot 
be completely dismissed. Similarly, HOME 
[Home Observation for Measurement of the 
Environment (Caldwell and Bradley 1984)] 
inventory scores were only available in a subset 
of 325 households. However, we compared 
the subjects with and without HOME score 
and found no significant differences in the 
population characteristics (data not shown). 
We performed a multivariable linear regres-
sion analysis and found that variables we used 
for adjustment in our main analysis collec-
tively explained 96.1% of variations in the 
HOME score. The demographic characteristics 
in our study population could also constrain 
our ability to explore lead effect in different 
subpopulations. For example, only 18 mothers 
(3%) reported having smoked during preg-
nancy, which limited our ability to assess the 
potential modifying effect of smoking during 
pregnancy on the associations between lead 
and ADHD symptoms. The socioeconomic 
class in our population also had a narrow 
range. This limits the generalizability of our 
findings in relation to the populations that are 
at the highest or lowest ends of the socioeco-
nomic spectrum, and may limit the power to 
detect the inter actions between lead exposure 
and socio economic class on ADHD-like 
outcomes. We recommend further study on 
effect of lead with regard to these aspects. The 
lead exposure data were obtained from two 
laboratories, which could result in varying 
degrees of measurement error across samples; 
however, our between-lab cross validation 
showed high consistency. We also encoun-
tered a fair number of subjects declining blood 
draw for blood lead measures, which confined 
our observations of exposure. We used impu-
tation to fill in missing values, and assumed 
values were missing at random in our impu-
tation models because declining phlebotomy 
is unlikely correlated to the blood lead level. 
Comparing our analyses with imputed data 
to the complete case analysis, we observed 
slight differences in estimated associations. 
This may be attributable to the fact that 
removing subjects with missing values from the 
analysis assumes data are missing completely 
at random; this is a strong assumption and is 
unlikely to be met because those who declined 
phlebotomy tended to be younger. Finally, our 
analysis examined the cross-sectional associa-
tion between lead measured at the same time 
as the behavioral assessment. Future studies 
should examine the independent effect of 
perinatal lead exposures and their potential 
modifying role on the effect of concurrent 
exposures. There are few studies that have 
linked perinatal lead exposures to ADHD 
in childhood (Kim et al. 2013; Yolton et al. 
2014). It could also be that other measures 
of exposure, such as cumulative lead levels or 
blood lead measured at other time points, may 
be more etiologically relevant.
Nonetheless, our study has the advantages 
of a relatively large sample size, comprehen-
sive evaluation of socioeconomic status, and 
estimates of maternal parenting behavior. We 
took advantage of the longitudinal design of 
the parent study by including maternal ciga-
rette smoking during pregnancy and infant 
birth weight in the models to control for these 
potentially confounding effects and to exclude 
any indirect effect of prenatal lead exposure 
that can be reflected on birth weight (Nishioka 
et al. 2014). Our study also has a good repre-
sentation of a low- to middle-class urban 
Mexican population and accurate estimate of 
concurrent lead exposure. Our findings also 
encourage additional explorations on the 
associations between lead exposure and other 
behavior problems, such as delinquent behavior 
and violence, which could have more serious 
impacts to the society and public health.
Conclusions
In summary, our study concurs with previous 
studies demonstrating an association of 
concurrent lead exposure with ADHD-
symptoms. In particular, we observed an asso-
ciation between lead and hyperactivity and 
impulsivity behaviors when concurrent blood 
lead was ≤ 5 μg/dL. However, this association 
was attenuated when levels were > 5 μg/dL, 
which may explain why behavior problems 
are not often linked with lead exposure on 
an individual basis, given the lack of a clear 
dose–response relationship at levels more typi-
cally characterized as “elevated.” The potential 
impact of low-level lead exposure on a popula-
tion basis is large and raises a serious public 
health concern particularly in areas where envi-
ronmental lead contamination continues.
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